Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An announcement from Idexx Laboratories ( (IDXX) ) is now available.
IDEXX Laboratories has approved a Nonqualified Deferred Compensation Plan allowing select management and high-earning employees to defer parts of their compensation. The Plan provides flexibility in deferral options and includes provisions for discretionary company contributions, promising potential benefits for both the company and its participants.
More about Idexx Laboratories
IDEXX Laboratories, Inc. operates in the healthcare industry, specializing in veterinary diagnostics and information technology solutions. The company focuses on providing innovative products and services for the animal health, water testing, and dairy markets.
YTD Price Performance: -21.25%
Average Trading Volume: 614,497
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $35.79B
For a thorough assessment of IDXX stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Broadcom Stock
- ‘Get in for 2025 Gains,’ Says Cowen on Amazon Stock
- Top Analyst Sets the Stage for Nike Stock Ahead of Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
